Adoptive T cell therapy - Immune monitoring and MHC multimers

Clinical Immunology

Volumn 106, Issue 1, 2003, Pages 5-9

  Yee, Cassian ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 2; MELAN A; MELANOMA ANTIGEN; POLYMER;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; B LYMPHOCYTE ACTIVATION; CANCER IMMUNOTHERAPY; CELL SURVIVAL; CLINICAL TRIAL; DENDRITIC CELL; HUMAN; IMMUNOSTIMULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; METASTASIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0037288124     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(02)00015-3     Document Type: Review

References (23)

1. Yee C., Riddell S.R., Greenberg P.D. Prospects for adoptive T cell therapy. Curr. Opin. Immunol. 9:1997;702-708.
2. Van den Eynde B.J., van der Bruggen P. T cell defined tumor antigens. Curr. Opin. Immunol. 9:1997;684-693.
3. van der Bruggen P., Traversari C., Chomez P., Lurquin C., De Plaen E., Van den Eynde B., Knuth A., Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254:1991;1643-1647.
4. Maus M.V., Thomas A.K., Leonard D.G., Allman D., Addya K., Schlienger K., Riley J.L., June C.H. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB. [see comments.] Nat. Biotechnol. 20:2002;143-148.
5. S.R. Riddell, E.H. Warren, D. Lewinsohn, C. Yee, P.D. Greenberg, Reconstitution of immunity by adoptive immunotherapy with T cells, in: K. Schindhelm, R. Nordon. (Eds.), Ex vivo cell Therapy, Academic Press, New York.
6. Yee C., Savage P.A., Lee P.P., Davis M.M., Greenberg P.D. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J. Immunol. 162:1999;2227-2234.
7. Greenberg P.D. Adoptive T cell therapy of tumors Mechanisms operative in the recognition and elimination of tumor cells . Adv. Immunol. 49:1991;281-355.
8. Yee C., Greenberg P.D. Modulating T cell immunity to tumors New strategies for monitoring T cell responses . Nat. Rev. Cancer. 2:2002;409-412.
9. Yee C., Riddell S.R., Greenberg P.D. In vivo tracking of tumor-specific T cells [Review]. Curr. Opin. Immunol. 13:2001;141-146.
10. Coulie P.G., Karanikas V., Colau D., Lurquin C., Landry C., Marchand M., Dorval T., Brichard V., Boon T. A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc. Nat. Acad. Sci. USA. 98:2001;10290-10295.
11. Pongers-Willemse M.J., Verhagen O.J., Tibbe G.J., Wijkhuijs A.J., de Haas V., Roovers E., van der Schoot C.E., van Dongen J.J. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia. 12:1998;2006-2014.
12. Altman J.D., Moss P.A.H., Goulder P.J.R., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. [published erratum appears in Science (1998) Jun 19;280(5371):1821] Science. 274:1996;94-96.
13. McMichael A.J., O'Callaghan C.A. A new look at T cells. J. Exp. Med. 187:1998;1367-1371.
14. Lee P.P., Yee C., Savage P.A., Fong L., Brockstedt D., Weber J.S., Johnson D., Swetter S., Thompson J., Greenberg P.D., Roederer M., Davis M.M. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5:1999;677-685.
15. Yee C., Thompson J.A., Roche P., Byrd D.R., Lee P.P., Piepkorn M., Kenyon K., Davis M.M., Riddell S.R., Greenberg P.D. Melanocyte destruction after antigen-specific immunotherapy of melanoma Direct evidence of T cell-mediated vitiligo . J. Exp. Med. 192:2000;1637-1644.
16. Yee C., Thompson J.A., Byrd D., Riddell S.R., Roche P., Celis E., Greenberg P.D. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma In vivo persistence, migration, and antitumor effect of transferred T cells . Proc. Natl. Acad. Sci. USA. 99 (75):2002;16168-16173.
17. Jager E., Gnjatic S., Nagata Y., Stockert E., Jager D., Karbach J., Neumann A., Rieckenberg J., Chen Y.T., Ritter G., Hoffman E., Arand M., Old L.J., Knuth A. Induction of primary NY-ESO-1 immunity CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers . Proc. Nat. Acad. Sci. USA. 97:2000;12198-12203.
18. Thurner B., Haendle I., Roder C., Dieckmann D., Keikavoussi P., Jonuleit H., Bender A., Maczek C., Schreiner D., von den Driesch P., Brocker E.B., Steinman R.M., Enk A., Kampgen E., Schuler G. Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190:1999;1669-1678.
19. Fisher B., Packard B.S., Read E.J., Carrasquillo J.A., Carter C.S., Topalian S.L., Yang J.C., Yolles P., Larson S.M., Rosenberg S.A. Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J. Clin. Oncol. 7:1989;250-261.
20. Brodie S.J., Patterson B.K., Lewinsohn D.A., Diem K., Spach D., Greenberg P.D., Riddell S.R., Corey L. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death. [see comments] J. Clin. Invest. 105:2000;1407-1417.
21. Mitchell M.S., Darrah D., Yeung D., Halpern S., Wallace A., Voland J., Jones V., Kan-Mitchell J. Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope. J. Clin. Oncol. 20:2002;1075-1086.
22. Dudley M.E., Wunderlich J., Nishimura M.I., Yu D., Yang J.C., Topalian S.L., Schwartzentruber D.J., Hwu P., Marincola F.M., Sherry R., Leitman S.F., Rosenberg S.A. Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J. Immunother. 24:2001;363-373.
23. Dubey, P., Su, H., Adonai, N., Du, S., Braun, J., Phelps, M., Gambhir, S., 2002 Visualization of adoptively transferred immune T lymphocytes at the tumor site using positron emission tomography. FOCIS meeting, Abstract 327.